Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

3.0K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
3.0K
Cancer Vaccines01:30

Cancer Vaccines

581
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
581
Cancer Survival Analysis01:21

Cancer Survival Analysis

481
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
481
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Elevated prostate specific antigen due to indwelling urethral catheterisation: myth or fact? A systematic review and meta-analysis.

World journal of urology·2026
Same author

Artificial intelligence in urology: A review of United States Food and Drug Administration-cleared devices.

BJU international·2026
Same author

Multicentre validation of the PRECISE scoring system for prostate MRI during active surveillance.

European radiology·2026
Same author

PRECISE Version 2: Essential Tips for Prostate Cancer Monitoring Using MRI.

Radiographics : a review publication of the Radiological Society of North America, Inc·2026
Same author

Impact of comorbidity on patient reported outcome measures for men with localised prostate cancer.

BMC urology·2026
Same author

Reply to the Letter to the Editor: Variation in prostate cancer growth rates in an MRI-based active surveillance cohort.

European radiology·2026
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
Ver todos los artículos relacionados

Video Experimental Relacionado

Updated: Oct 25, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.4K

Cáncer de próstata

Shahneen Sandhu1, Caroline M Moore2, Edmund Chiong3

  • 1Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.

Lancet (London, England)
|August 9, 2021
PubMed
Resumen
Este resumen es generado por máquina.

Los avances en el tratamiento del cáncer de próstata incluyen terapias personalizadas dirigidas a las vías de reparación del ADN y una mejor supervivencia con nuevos inhibidores de andrógenos para la enfermedad metastásica. La investigación futura se centra en la caracterización molecular y en nuevos tratamientos como los radioisótopos y la inmunoterapia.

Más Videos Relacionados

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

11.0K
Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
07:01

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Published on: August 29, 2016

14.6K

Videos de Experimentos Relacionados

Last Updated: Oct 25, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.4K
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

11.0K
Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
07:01

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Published on: August 29, 2016

14.6K

Área de la Ciencia:

  • En el campo de la oncología
  • Investigación del cáncer genitourinario

Sus antecedentes:

  • El tratamiento del cáncer de próstata está evolucionando rápidamente.
  • La comprensión del paisaje genómico y la biología ha avanzado.
  • Los métodos de imagen sensitivos han mejorado el diagnóstico y la estadificación.

Objetivo del estudio:

  • Para revisar los avances recientes en el tratamiento del cáncer de próstata.
  • Destacar el impacto de las terapias personalizadas y las nuevas estrategias de tratamiento.
  • Para discutir las direcciones futuras en la investigación del cáncer de próstata.

Principales métodos:

  • Revisión de la literatura y la práctica clínica actuales.
  • Análisis de los datos de caracterización genómica y molecular.
  • Evaluación de los nuevos enfoques terapéuticos.

Principales resultados:

  • Las terapias personalizadas dirigidas a las vías de reparación del ADN están validadas.
  • Las terapias dirigidas a las metástasis son prometedoras para la enfermedad oligometastásica.
  • Los nuevos inhibidores de la vía androgénica mejoran significativamente la supervivencia en el cáncer de próstata metastásico.

Conclusiones:

  • La caracterización molecular tendrá un impacto en el manejo clínico de la enfermedad localizada y avanzada.
  • Los radioisótopos dirigidos y la inmunoterapia ofrecen opciones de tratamiento prometedoras para el futuro.
  • La investigación continua es crucial para mejorar los resultados de los pacientes con cáncer de próstata.